Stepwise Development of Committed Progenitors in the Bone
Ϫ Mac-1 Ϫ CD2 Ϫ CD44 ϩ CD16 ϩ phenotype that are capable of generating T cells in vitro (1) and in vivo (2) . Because these progenitors only developed into T cells and no other lineages, they were called committed T cell progenitors (CTPs). 4 CTPs have not rearranged the TCR V␤ genes, and express mRNA for RAG-1, RAG-2, and preT␣ (1, 2 (1) . Rare cells with the CIP phenotype are found in the fresh bone marrow of adult mice, and can rapidly generate mature TCR␣␤ ϩ T cells also in vitro (1) .
Phenotypic CTPs can be found in the bone marrow of athymic nu/nu mice, but these CTPs are not functional due to abnormalities in the nu/nu bone marrow microenvironment that result in defective differentiation from hemopoietic stem cells (3) . In contrast, hemopoietic stem cells from wild-type hosts differentiated into functional CTPs in the bone marrow of irradiated thymectomized wild-type hosts within a few weeks after adoptive transfer (3) . These extrathymically derived CTPs were able to develop into mature TCR␣␤ ϩ T cells after transfer into additional irradiated wild-type hosts. The latter experiments demonstrated that CTPs are prethymic (thymus-independent) progenitors (3) . Studies of the normal human bone marrow have identified early progenitors with characteristics shared by CTPs and/or CIPs, and are committed to the T cell lineage as judged by the expression of T cell lineagespecific genes, active rearrangement of TCR gene segments, and expression of pre-TCR␣ receptors on the cell surface associated with intracellular CD3 (4) . Although the mouse CTPs were able to generate mature T cells in vitro in the absence of thymic stromal cells, we did not determine whether the CTPs can generate T cells in vivo in athymic mice nor whether such extrathymic T cells would be functional with a full V␤ repertoire.
The current study compares T cell lineage surface receptors, gene expression, and ability of the CTPs and the CIPs in the bone marrow, and T cell progenitors in the thymus to generate mature T cells in athymic nu/nu mice. Key surface receptor differences between the CTPs and CIPs include the down-regulation of CD16 with the concomitant up-regulation of CD5 and CD122 by the CIPs. The more mature CIPs also down-regulate expression of pre-T␣, RAG-1, and RAG-2 genes, and up-regulate expression of CD3⑀ and TCR V␤8 genes in association with the TCR␤ gene rearrangement. Although these patterns are similar to progenitor maturation in the thymus, key differences were observed as well. In addition, we showed that limiting dilutions of wild-type mouse CTPs transferred to irradiated nu/nu hosts can generate CD4 ϩ and CD8 ϩ TCR␣␤ ϩ T cells with a full V␤ receptor repertoire in the absence of the thymus. Progenitors in the thymus failed to generate mature T cells in the nu/nu hosts. Furthermore, we determined that extrathymically derived T cells from CTPs are functional and can protect against viral infection.
Farms), and RAG-1 Ϫ/Ϫ C57BL/6 CD45.2 mice (Taconic Farms) were used at 8 -12 wk old. All experiments were performed in compliance with National Institutes of Health and institutional guidelines, and were approved by the Stanford Administrative Panel on Laboratory Animal Care.
Antibodies
Fluorochrome-conjugated anti-CD2 (RM2-5), CD3⑀ (145-2C11), CD4 (RM4-5), CD11b (Mac-1, M1/70.15), CD16/CD32 (2.4G2), CD25 (IL-2R␣, 7D4), CD45R (B220, RA3-6B2), CD45.1 (Ly-5.2, A20.1.7), CD45.2 (Ly-5.1, AL1-4A2), CD122 (IL-2R␤, TM-␤1), CD127 (IL-7R␣, B12-1), GR-1 (RB6-8C3), NK1.1 (PK136), TCR␣␤ (H57-597), and TCR␥␦ (GL3) mAbs were obtained from BD Pharmingen. Fluorochrome-conjugated CD4 (CT-CD4), CD8␣ (CT-CD8), CD25 (PC61-5.3), CD90.2 (Thy-1.2, 5a-8), rat IgG2b, and hamster IgG1 isotype controls were obtained from Caltag Laboratories. The following Abs were conjugated as previously described and directed to (3): CD3⑀ (KT31.1), CD4 (GK1.5), CD5 (53-7.3), CD8␣ (53-6.7), CD11b (Mac-1, M1/70), CD24 (heat stable Ag, M1/69), CD44 (IM781), CD45R (B220, RA3-6B2), CD45.1 (Ly-5.2, A20.1.7), CD45.2 (Ly-5.1, AL1-4A2), CD90.2 (Thy-1.2, 5a-8), CD117 (c-Kit, 2B8), GR-1 (RB6-8C3), NK1.1 (136TC), and Sca-1 (E13-161).
Cell preparation and immunofluorescent staining
Single cell suspensions of bone marrow, spleen, and thymus cells were obtained, as previously described (1, 2) . All single cell suspension samples were pretreated with purified anti-CD16/32 at saturation to block Fc␥RIIIA/B receptors. Following CD16/32 block, the samples were incubated with various combinations of fluorochrome-or biotin-conjugated Abs at saturation for 15-20 min on ice. In the case of biotin-conjugated reagents, counterstaining for 5 min with fluorochrome-conjugated streptavidin was performed. After staining, cells were washed and resuspended in fresh staining medium containing PBS without calcium or magnesium (BioWhittaker) with 1% FBS (HyClone) before sorting or analysis. Stained samples were resuspended in staining medium with propidium iodide at 0.5 g/ml (Sigma-Aldrich).
Eight-color FACS analysis and sorting were done using a highly modified dual laser (488-nm argon and 599-nm dye lasers) FACS III (BD Biosciences) with four-decade logarithmic amplifiers (5) and a Moflo console (DakoCytomation). Four-color sorting was done using the FACSVantage (BD Biosciences), while one-to three-color sorting was done using the FACStar (BD Biosciences). Data were analyzed using Flowjo software (Tree Star) as either histograms or two-parameter 5% probability plots.
Isolation of CTPs and CIPs
The isolation of CTPs has been previously described (1) . In brief, bone marrow of adult mice was enriched by incubation with biotin-conjugated anti-Thy-1.2 mAb (5a-8; Caltag Laboratories), incubated further with streptavidin-conjugated immunomagnetic beads, and positively selected on MACS-LS magnetic separation columns (Miltenyi Biotec), according to the manufacturer's specifications. For molecular genetics and extended surface phenotype studies, the positively selected marrow was stained for both T cell lineage (CD3) and non-T cell lineage (B220, Mac-1, NK1. 
Isolation of total RNA and RT-PCR technique
Total RNA was extracted from sorted cells using the RNeasy Mini Kit (Qiagen). For RNA isolation, between 0.3 and 5 ϫ 10 5 cells were used. RNA was then reversed transcribed using random hexamer primers, followed by PCR amplification. Optimal conditions for PCR amplification for ␤-actin message, to be used as an internal standard, were established by titration of the number of amplification cycles using primers specific for ␤-actin, followed by densitometry analysis to measure ethidium bromide luminescence of PCR products. PCR products were identified on agarose gels with ethidium bromide staining. RAG-1, RAG-2, and IL-7R␣ primers were used for RT-PCR, as previously described (6) . Additional primers used for RT-PCR were designed using Oligo4.03 (National Biosciences) with the sequences found in GenBank (7) under the listed accession number: CD3⑀ (M23376), 5Ј-CACCCTGCTACTCCTTGTTC-3Ј and 5Ј-TTA CAGAATCCATCCCAGAG-3Ј; GATA-3 (X55123), 5Ј-GGGGCCTCT GTCCGTTTACC-3Ј and 5Ј-CCTTCTGTGCTGGATCGTGC-3Ј; T cellspecific factor-1 (TCF-1) (X61385), 5Ј-CTACTCTGCCTTCAATCT GC-3Ј and 5Ј-TTGATGACTGGCTTCTTAGC-3Ј; V␤8 (AE000664), 5Ј-TACAAGGCCTCCAGACCAAG-3Ј; pre-T␣.1 (U16958), 5Ј-GGCTC CACCCATCACACTGC-3Ј and 5Ј-CCATTTACAAGAGGCAGATCAC 3Ј; pre-T␣.2, 5Ј-TGCTGGTGGTTTGCCTGGTC-3Ј and 5Ј-GGGA GCAGTAGTGTCCAGCATC-3Ј; TCR C␤ (AE000665), 5Ј-AGGCTAC CCTCGTGTGCTTG-3Ј and 5Ј-TGACCAGCACAGCATATAGG-3Ј; ␤-actin (X03672), 5Ј-TGGGTCAGAAGGACTCCTATG-3Ј and 5Ј-ACCAGACAGCACTGTGTTGGC-3Ј; CCR9 (AJ132336), 5Ј-TGCT GATCTGCTCTTTCTTG-3Ј and 5Ј-GTGCTTGGATGACTTCTTGG-3Ј; CXCR4 (U59760), 5Ј-CTAGGATGAGGATGACTGTCG-3Ј and 5Ј-ACCTCTACAGCAGCGTTCTC-3Ј; Aiolos (AF001293), 5Ј-ATCGAAG CAGTGCCGCTTCTCACC-3Ј and 5Ј-GTGTGCGGGTTATCCTGCATT AGC-3Ј; PU.1 (M38252), 5Ј-TGTGCTTCCCTTATCAAACC-3Ј and 5Ј-TCTTCACCTCGCCTGTCTTG-3Ј; Id2 (AF077860), 5Ј-GCGAGTGCA CATAAAAGACG-3Ј and 5Ј-ACGATAGTGGGATGCGAGTC-3Ј; Pax5 (NM_008782), 5Ј-ACGGCCACTCCCAGATGTAG-3Ј and 5Ј-TCTT GCGTTTGTTGGTGTCG-3Ј; Notch-1 (Z11886), 5Ј-TATGCCAGGT TATGAAGGTG-3Ј and 5Ј-TTCAGACTCCTTGCATACGC-3Ј; E2a (BC018260), 5Ј-CAGTGAGCGGAATGCCTATG-3Ј and 5Ј-TGGATA CAGCTGGGAGCGAG-3Ј. PCR used a single set of primers, except for pre-T␣ analysis, which used two nested primer pairs (pre-T␣.1 and pre-T␣.2).
RT-PCR analysis
Total RNA was extracted from 3-6 ϫ 10 4 sorted cells using an RNeasy Mini kit (Qiagen). RNA was reverse transcribed using random hexamer primers, and amplified by PCR using the following forward and reverse primers: 5Ј-TGGGTCAGAAGGACTCCTATG-3Ј and 5Ј-ACCAGACAG CACTGTGTTGGC-3Ј for ␤-actin; 5Ј-TACAAGGCCTCCAGACCA AG-3Ј and 5Ј-AGGATTGTGCCAGAAGGTAG-3Ј for the V␤8-C␤2 rearrangement; and 5Ј-GTGTCATCATGTCCCGTCTC-3Ј and 5Ј-CAAC CTTCCTCACAAATGTG-3Ј for the V␣8-C␣ rearrangement.
Cytokine production assay
Flat-bottom 96-well plates (Corning Glass) were coated for 90 min with 10 mg/ml purified anti-TNP mAb (A19-3, hamster IgG1, isotype control) or a 10 mg/ml combination of anti-CD3 mAb and CD28 mAb (clones 2C11 and 37.51, respectively; both hamster IgG1) diluted in RPMI 1640 (BioWhittaker) in the 5% CO 2 humidified incubator at 37°C. Following incubation, the coated wells were washed three times in complete RPMI 1640 medium.
Whole lymph node cells (1 ϫ 10 5 ) from C57BL/6 wild-type, nu/nu, or CTP-reconstituted nu/nu mice were used for cytokine stimulation in triplicate in a final volume of 0.2 ml/well. These cells were incubated for 48 h in the absence or presence of plate-bound anti-TNP Ab or plate-bound anti-CD3/CD28 Abs, or treated with a combination of 20 ng/ml PMA (Sigma-Aldrich) and 1 M ionomycin (Calbiochem). Following culture, the supernatants were harvested and frozen at Ϫ80°C. ELISA tests were performed following the manufacturer's specifications using Cytoscreen IL-2, IL-4, IL-10, and IFN-␥ mouse ELISA kits (BioSource International).
Protection against lethal murine CMV (MCMV) infection
Nu/nu mice reconstituted with 500 CTP were prepared, as described above. As controls, nu/nu mice were reconstituted with 2 ϫ 10 6 RAG-1
2) bone marrow cells alone or together with 1 ϫ 10 7 whole lymph node cells from CD45.1 C57BL/6 mice. Stocks of recombinant-type MCMV strain RM427 ϩ (8) were grown and titered on NIH 3T3 cells (American Type Culture Collection CRL1658), as described (9) . The titer of all stocks was confirmed at the time when mice were inoculated. All mice were infected i.p. with 10 6 PFU of MCMV 3 wk posttransplant. Mice were monitored for weight loss and signs of MCMV infection. Moribund mice were sacrificed, and the kidneys, liver, lungs, lymph nodes, salivary glands, and spleen were harvested for histological analysis.
Induction of graft-vs-host disease (GVHD)
Briefly, male BALB/c host mice were given a single dose of lethal whole body irradiation (950 cGy) from a 200 kV (20 mAb) source (Philips Medical Systems) at a rate of 72.5 cGy/min. Within 24 h after irradiation, the host mice were transplanted i.v. with 1.5 ϫ 10 6 T cell-depleted bone marrow and graded numbers of whole lymph node cells from C57BL/6 mice, as described previously (10) . Treatment with neomycin and penicillin was started concomitantly with the transplantation and terminated between 3 and 4 wk after transplantation. The mice were weighed weekly and monitored daily for survival and signs of GVHD, including kyphosis (hunched back), alopecia (hair loss), skin lesions, diarrhea, and facial swelling. Mean body weight and survival were determined 100 days after transplantation. Chimerism, as evidenced by the presence of H-2K bϩ cells in the spleen, was confirmed in all hosts by flow cytometry.
Results

Extended surface marker phenotype of CTPs and CIPs
Multicolor analysis of surface markers on CTPs and CIPs was performed to look for patterns reported to be present on other early progenitor cells, such as common lymphoid progenitors (CLPs), and hemopoietic stem cells (HSCs) in the marrow, and thymic and fetal blood progenitors (11) (12) (13) (14) (15) . One-color analyses of key markers were compared after bone marrow cells enriched with antiThy-1.2 immunomagnetic beads were gated for CD3 Fig. 1A . These cells were gated further for Thy-1.2 high cells, and the gated cells were analyzed for expression of CD2. Two discrete populations of Thy-1.2 high CD2 Ϫ and Thy-1.2 high CD2 ϩ cells (CTPs and CIPs, respectively) were observed, as shown in Fig. 1B . As previously shown (1), the gated CTPs expressed higher levels of CD16 than the CIPs (Fig. 1D ). In contrast, the CIPs expressed increased levels of CD44, CD5, and CD122 (IL-2R␤) as compared with the CTPs (Fig. 1 , C, G, and K, respectively). Fig. 1E shows that the large majority of both CTPs and CIPs express little or no CD25 (IL-2R␣). However, there is a small subset of CTPs that is CD25
ϩ . The CTPs and CIPs expressed intermediate levels of CD24 (HSA) (Fig. 1F ). Taken together, the data indicate that the CTPs have a CD44
ϩ CD25 Ϫ CD16 medium/high CD24 ϩ CD5 Ϫ phenotype similar to the most undifferentiated T cell progenitors described previously in the adult thymus, and in the fetal thymus and blood (11, 13, 14) . In contrast to the CTPs, the earliest progenitors in the thymus do not express high levels of Thy-1 (16) . With the exception of CD25, the CIPs have the CD44 high CD16 medium CD24 ϩ CD5 ϩ phenotype, characteristic of T cell progenitors further along the T cell developmental pathway (11, 13, 14) .
We evaluated the expression of Sca-1, c-Kit, and IL-7R␣ (CD127) on the CTPs and CIPs. The CTPs are predominantly Sca-1 Ϫ (Fig. 1H ), c-Kit ϩ (Fig. 1I) , and IL-7R␣ Ϫ (Fig. 1J ). However, a small subset of CTPs is Sca-1 low and IL-7R␣ low . In contrast, the CIPs are Sca-1 low (Fig. 1H ), c-Kit ϩ (Fig. 1I) , and IL-7R␣ Ϫ/low (Fig. 1J ). Background staining with isotype-matched irrelevant mAbs showed a peak channel of fluorescence that approximated channel 1 (data not shown), and overlapped with negative staining for CD25, Sca-1, CD5, CD127, and CD122 on CTPs.
In additional experiments, the expression of CD3, CD4, and CD8 on CTPs and CIPs was compared with that of mature splenic T cells. Fig. 1 , L, M, and N, shows one-color analyses for the intensity of staining of each marker on the gated cell populations. For mature T cells, spleen cells were stained for CD3, CD4, or CD8 vs light scatter, and the intensity of staining for each positive population was determined. Whereas the mature T cells showed bright staining for CD3, CD4, and CD8, the intensity staining of the latter markers on CIPs and CTPs was dull and similar to background (Fig. 1, L, M, and N) .
Expression of T cell lineage genes
We analyzed CTPs and CIPs for expression of T cell lineage genes by RT-PCR analysis using bone marrow cells enriched with antiThy-1 beads and then sorted for Thy-1.
Ϫ double-negative (DN) thymocytes, used as a control population, showed intense RT-PCR product bands for RAG-1, RAG-2, pre-T␣, and PU.1 genes (Fig. 1O) . The control cells confirmed previous studies that showed RAG-1, RAG-2, pre-T␣, and PU.1 gene expression in the DN population (17) (18) (19) (20) . In contrast, the sorted CIPs and control sorted splenic TCR␣␤ T cells showed either undetectable or faint bands for these genes. The sorted CIPs had intense bands for both the TCR V␤8 and CD3⑀ genes, as did the sorted splenic control T cells and DN thymocytes. These genes are expected to be expressed in the latter control cells because the pre-TCR complex that contains both a rearranged TCR␤ chain and CD3⑀ is present in the CD44 Ϫ CD25 ϩ DN thymus subpopulation (11) . However, only the CIPs and sorted T cells had intense bands for V␣8 indicative of TCR␣ chain gene rearrangement and expression. The CTPs expressed little or no RT-PCR product for either the rearranged TCR␤, TCR␣, or CD3⑀ genes. This is consistent with the absence of a rearranged TCR V␤8 gene segment. Furthermore, both CTP and CIP cells expressed very low levels of RNA for Notch-1 reported to be involved in T lineage commitment (21), whereas we could readily find PCR products for this receptor in sorted T cells and DN thymocyte populations. Both CTPs and CIPs expressed RNA for the IL-7R␣ gene and for the T cell-specific transcription factor genes GATA-3 and TCF-1 (22) . Moreover, the CTPs expressed RNA for TCR C␤, indicative of sterile transcripts made during the earliest stages of T cell development in extrathymic microenvironments (23) . All the populations tested had RNA for Aiolos and E2a genes, expressed only in lymphoid cells, as well as low, but detectable levels of Id-2 RNA, which is restricted to NK and T cell development (24 -27) .
Finally, both populations were tested for expression of RNA of the chemokine receptors CCR9 and CXCR4. CCR9 is expressed on both thymocytes and mature T cells (28) , and is the receptor for the thymus-expressed chemokine (29) . CXCR4 is the receptor for stromal cell-derived factor-1, a chemokine produced in multiple tissues, including the thymus and bone marrow (30) . Both the CTP and CIP populations showed intense bands for these chemokine receptors (Fig. 1O) .
Reconstitution of T cells in nu/nu hosts using wild-type CTPs
Our previous studies showed that CTPs generated mature T cells in the lymphoid tissues of irradiated euthymic adoptive hosts (2, 3). In the current study, CTPs were examined for their capacity to generate T cells in athymic hosts. CTPs obtained from the marrow of wild-type CD45.1 C57BL/6 mice were sorted (Fig. 2) , and 250 were injected i.v. into groups of five CD45.2/C57BL/6 athymic nu/nu hosts that were coinjected with 1 ϫ 10 6 CD45.2 RAG-1 Ϫ/Ϫ marrow cells. The host lymph node, spleen, and bone marrow cells were harvested and analyzed 1, 2, 4, and 8 wk later. Two-color analysis of cells stained for TCR␣␤ vs CD45.1 was performed at each time point. At 1 wk, CD45.1 ϩ cells accounted for Ͻ1% of cells in all three tissues (data not shown). However, at 2 wk, TCR␣␤ ϩ T cells derived from the CTPs accounted for 31.2% of lymph node cells (Fig. 2) . The percentage increased to 49.5% at 8 wk. In control animals injected with RAG-1 Ϫ/Ϫ marrow cells alone, only 0.02% of lymph node cells were TCR␣␤ ϩ T cells at 8 wk. Background control staining was up to 0.1%. Control nu/nu mice had ϳ0.1-0.8% of TCR␣␤ ϩ T cells in the lymphoid tissues before irradiation and cell transfer (bottom panels, Fig. 2 ).
Spleen cells of the nu/nu hosts injected with CTPs contained 11.5% of TCR␣␤ ϩ CD45.1 ϩ cells at 2 wk, and the percentage rose to 39.8% at 8 wk. In the absence of CTPs, the host spleen cells contained 0.01% of the CD45.1 ϩ T cells. A similar pattern was observed in the bone marrow, although the percentage of T cells was much lower than in the lymph nodes and spleen, as expected. It was possible that CD45.1 ϩ T cell outgrowth from injected CTPs were generated from mature TCR␣␤ ϩ T cells that contaminated the purified CTPs. Accordingly, control irradiated athymic hosts were injected with RAG-1 Ϫ/Ϫ marrow and 250 sorted bone marrow CD45.1 TCR␣␤ ϩ T cells (BMTC) instead of CD45.1 CTPs from the Thy-1.2-enriched donor bone marrow. Hosts that received the sorted T cells had Ͻ1% TCR␣␤ ϩ T cells in the lymph nodes, spleen, and bone marrow at 8 wk (Fig. 2) . In additional experiments, we tested the ability of 250 sorted CD4
Ϫ cells from the CD45.1 wild-type thymus (stage I DN thymocytes) to reconstitute the irradiated nu/nu hosts. Hosts that received the CD44 high CD25
Ϫ thymic progenitors had Ͻ1% TCR␣␤ ϩ T cells in the lymphoid tissues at 4 wk (Fig. 2) .
The kinetics of the increase in the absolute number of CTPderived T cells in the spleen, lymph nodes, and bone marrow are shown in Table I . At 2 wk after injection of 250 CTPs, a mean of 1.3 ϫ 10 6 CD45.1 ϩ T cells was harvested from the spleen, 0.54 ϫ 10 6 from cervical and axillary lymph nodes, and 0.21 ϫ 10 6 from the marrow cells from both femurs and tibias. The absolute numbers in the spleen and bone marrow increased ϳ2-fold from 2 to 8 wk, and those in lymph nodes declined slightly (Table I ). The total number of CD45.1
ϩ T cells in all three tissues (ϳ3 ϫ 10 6 ) indicates an expansion of ϳ10,000-fold as compared with that of the injected CTPs (250 cells). As compared with untreated wild-type C57BL/6 mice, the absolute number was not reduced in the bone marrow, but was reduced 10-fold in the spleen and lymph nodes (data not shown). This suggests that the intact thymus pathway is still required to achieve wild-type levels of TCR␣␤ T cells in the periphery.
When 250 CTPs from the bone marrow of nu/nu C57BL/6 mice were used instead of wild-type CTPs to reconstitute the T cells of irradiated congenic nu/nu hosts, then the absolute numbers of CTP-derived T cells at 8 wk were Ͻ0.001 ϫ 10 6 (below limit of deletion) in each tissue (Table I ). In addition, the injection of 1 ϫ 10 3 sorted Thy-1 low Sca-1 ϩ c-Kit ϩ HSCs from the bone marrow of wild-type C57BL/6 donors into irradiated congenic nu/nu hosts resulted in minimal T cell reconstitution as compared with that with 250 wild-type CTPs (Table I ). The latter result was expected, because wild-type stem cells fail to develop into functional CTPs in the nu/nu bone marrow after adoptive transfer (3). The injection of 250 sorted TCR␣␤ ϩ T cells (BMTC) from the wildtype bone marrow resulted in Ͻ0.001 ϫ 10 6 T cells in the lymphoid tissues of the nu/nu hosts at 8 wk (Table I (Table I) .
To determine whether CD45.1 ϩ cells derived from the injected CTP were restricted to the T cell lineage, host spleen cells harvested at 4 wk were stained for a variety of markers that identify B cells (B220), macrophages (Mac-1), granulocytes (Gr-1), and NK cells (NK1.1) in addition to T cells (TCR␣␤) and T cellassociated markers (CD4 and CD8). Fig. 3A shows that ϳ17% of host spleen cells contained CD45.1 ϩ TCR␣␤ ϩ cells, and Ͻ1% of the spleen cells were CD45.1 ϩ cells expressing the non-T cell lineage markers (B220, Gr-1, Mac-1, NK1.1). A small population of CD45.1 TCR␣␤ low/Ϫ and CD45.1 CD4 Ϫ CD8 Ϫ cells was observed in the spleen (Fig. 3B, top panels) . To further characterize these cells, CD45.1-gated cells were analyzed for Thy-1.2 vs CD2 and TCR␣␤ ϩ vs CD2 markers. Fig. 3B shows that 99.6% of the gated CD45.1 cells expressed both Thy-1.2 and CD2 markers, and ϳ12% of these fail to express high levels of TCR␣␤ or any of the other markers. Thus, the latter cells derived from the injected CTP express the Thy-1 ϩ CD2 ϩ Lin Ϫ phenotype present on intermediate T cell progenitors that are rapidly generated by CTPs in vitro (1) , and are present also in the wild-type bone marrow (Fig. 1B) .
The expression of CD4 vs CD8 markers on gated CD45.1 TCR␣␤ ϩ cells in the host spleen at 4 and 8 wk is also shown in Fig. 3B . Approximately 65-68% of the gated cells were singlepositive CD4
ϩ cells, and ϳ26 -28% were single-positive CD8 ϩ cells. The latter cells were almost all CD8␣␤ ϩ cells, as determined by staining for CD8␣ vs CD8␤ (data not shown). A small population (2.8%) of gated cells was CD4 ϩ CD8 ϩ double-positive cells at 4 wk, and a discrete population of the latter cells was not observed at 8 wk. Some CD4 Ϫ CD8 Ϫ T cells were observed at both time points (Fig. 3B) . Thus, almost all cells derived from the injected CTPs were members of the T cell lineage, and among the latter cells almost all were single-positive CD4 ϩ or CD8 ϩ T cells. To provide an estimate of the precursor frequency of functional progenitors, we injected 100, 150, or 250 CTPs into groups of 10 irradiated nu/nu hosts, and observed the fraction without T cell reconstitution. After injection, 0 of 10, 6 of 10, and 10 of 10 hosts, respectively, showed reconstitution of the lymph nodes 4 wk later. This suggests that the precursor frequency is in the range of 1 precursor in ϳ100 -250 purified CTPs. Wild-type CD45.1 CTPs generated a normal repertoire of V␤ receptors near limit dilution (250 CTPs injected), as judged by the percentage of V␤3 ϩ , V␤6 ϩ , and V␤8 ϩ (2.8, 7.0, and 19.4%, respectively) among lymph node T (Thy-1.2 ϩ ) cells in reconstituted hosts at 4 wk (Fig. 4A) . These percentages were similar to those reported among TCR␣␤ ϩ T cells in the normal C57BL/6 spleen (31).
Rearrangements of V␤ genes and V␤ repertoire in reconstituted nu/nu hosts
We performed RT-PCR analysis on mRNA from the sorted CTPs from wild-type C57BL/6 bone marrow to look for expression of V␤8 and V␣8 genes, and failed to detect an appropriate size cDNA fragment (Fig. 4B) . However, the sorted CD45.1 ϩ TCR␣␤ ϩ T cells derived from CTPs injected into the congenic nu/nu hosts showed expression of both genes (Fig. 4B) . Sorted lymph node T cells from wild-type mice showed expression of both genes also, but an equivalent number of whole nu/nu lymph node cells failed to provide a detectable signal (Fig. 4B) . Samples from all cell sources showed a dense band for ␤-actin after amplification (Fig. 4B) .
The results using adoptive nu/nu C57BL/6 congenic hosts indicated that the transferred CTPs generate mature CD4 ϩ and CD8 T cells with a full V␤ receptor repertoire. To study negative selection, we injected 500 CTPs from the bone marrow of Thy-1.1 BALB/c mice donors along with 1 ϫ 10 6 Thy-1.2 BALB/c RAG-2 Ϫ/Ϫ bone marrow cells into lethally irradiated Thy-1.2 nu/nu BALB/c hosts. We compared the V␤ repertoires of sorted CTPderived T cells (Thy-1.1 ϩ ) from the spleens of BALB/c nu/nu hosts 4 wk after the adoptive transfer with that of wild-type BALB/c and C57BL/6 T cells.
The percentages of V␤ receptor-expressing cells in the spleen among gated Thy-1.1 ϩ cells were determined, and the ratios of each V␤ to that of the predominant nondeleted V␤8 ϩ cells were compared. As shown in Table II , statistically significant reductions of these V␤n:V␤8 ratios ( p Ͻ 0.05; Student's t test of independent means) were observed for V␤3, V␤5, V␤11, and V␤12 receptors that are expected to be deleted in BALB/c as compared with wildtype C57BL/6 mice (Table II) . The V␤ receptor deletion pattern observed in the CTP-reconstituted nu/nu BALB/c-adoptive hosts was similar to that observed in the wild-type BALB/c mice (Table  II) . Thus, negative selection of the CTP-derived T cells occurred extrathymically in vivo.
Function of T cells in reconstituted nu/nu hosts
To determine whether the T cells in the lymph nodes of the CTPreconstituted nu/nu mice were functional, in vitro assays of cytokine secretion were performed in which 1 ϫ 10 5 lymph node cells from the latter mice were harvested 8 wk after reconstitution with 250 CTPs and compared with an equal number of lymph node cells obtained from untreated C57BL/6 wild-type mice and untreated C57BL/6 nu/nu mice. Cells were stimulated with a combination of anti-CD3 and anti-CD28 mAbs bound to the surface of 96-well plates, and control cultures contained an irrelevant (anti-TNP) mAb or no mAb. Supernatants were collected at 48 h and cytokines were measured by ELISA. Fig. 5, A and B, shows that wildtype lymph node cells secreted ϳ1400 pg/ml IL-2 and 400 pg/ml IFN-␥. Although the CTP-reconstituted nu/nu lymph node cells secreted ϳ10-fold less IL-2, they secreted similar levels of IFN-␥ (ϳ350 pg/ml). Control cultures with irrelevant mAb or no mAb secreted no detectable IL-2 or IFN-␥, and lymph node cells from untreated nu/nu mice failed to secrete the cytokines in response to anti-CD3/CD28 stimulation. Supernatants were also assayed for the presence of IL-4 and IL-10, and all culture supernatants, including those with wild-type lymph node cells, contained Ͻ100 pg/ml cytokine after stimulation with anti-CD3/CD28 mAb (data not shown).
In additional experiments, CTP-reconstituted nu/nu mice were challenged with MCMV to determine whether the extrathymically derived T cells afforded protection against a lethal viral infection. The irradiated CD45.2 nu/nu hosts were reconstituted with 2 ϫ 10 6 bone marrow cells from CD45.2 RAG-1 Ϫ/Ϫ mice and 500 CTPs from CD45.1 wild-type mice. Control mice received either RAG-1 Ϫ/Ϫ bone marrow cells alone or RAG-1 Ϫ/Ϫ bone marrow cells and 1 ϫ 10 7 lymph node cells from CD45.1 wild-type mice. Three weeks after the injection of the cells, the three groups of mice were challenged with 1 ϫ 10 6 PFU of MCMV, and mice were monitored for weight loss, clinical signs, and survival thereafter. As shown in Fig. 5C , mice reconstituted with RAG-1 Ϫ/Ϫ bone marrow cells alone all died by 24 days after the MCMV challenge. These mice developed diffuse abdominal swelling (ascites) ϳ1 wk before they died. The mice reconstituted with marrow cells and wild-type CTPs remained healthy after the MCMV injection, and all survived without weight loss until day 56 when they were sacrificed for harvesting of tissues (Fig. 5C) . At that time, ϳ50% of cells in the lymph nodes were TCR␣␤ ϩ T cells derived from CTPs (CD45.1). The group given marrow and wild-type lymph node cells remained healthy also until sacrifice at day 56.
Histopathological analysis of tissue sections of the liver stained with H&E was obtained either at the time of death in the group given marrow cells alone or at the time of sacrifice for the two other groups. Multiple patchy areas of liver parenchymal cell necrosis associated with inflammatory cell infiltrates were observed in the group given marrow cells alone, and no evidence of necrosis or inflammation was observed in the group given marrow and wild-type lymph node cells (data not shown). Although some areas of necrosis and inflammation were observed in the livers from mice given marrow cells and CTPs, the extent was reduced as compared with that of mice given marrow cells alone.
Protection against MCMV is predominantly mediated by CD8 ϩ T cells (32) . We also tested the functional capacity of lymph node cells from CTP-reconstituted C57BL/6 nu/nu mice to induce lethal GVHD in BALB/c mice, because tissue injury in this disease is mediated predominantly by CD4 ϩ T cells (10) . Groups of lethally irradiated (950 cGy) BALB/c mice were given injections of T cell-depleted wild-type C57BL/6 bone marrow cells alone or with 0.5 ϫ 10 5 or 2 ϫ 10 5 lymph node cells from CTP-reconstituted nu/nu mice, untreated nu/nu mice, or untreated wild-type mice (Fig. 5, D and E) . Whereas the injection of 0.5 and 2 ϫ 10 5 wildtype lymph node cells caused diarrhea, weight loss, and the death of 20 and 100% of the allogeneic hosts, respectively, during a 100-day observation period, all mice in the groups given either no lymph node cells, or 2 ϫ 10 5 CTP-reconstituted nu/nu lymph node cells, or 2 ϫ 10 5 nu/nu lymph node cells remained healthy and survived at least 100 days (Fig. 5, D and E) . Thus, the CTP-reconstituted lymph node cells had little capacity to induce lethal GVHD even when the absolute number of lymph node CD4 ϩ T cells injected was at least as high as that of untreated wild-type CD4 ϩ T cells (2 ϫ 10 5 nu/nu reconstituted vs 0.5 ϫ 10 5 wild-type lymph node cells injected, respectively).
Discussion
Our data show that the CTPs in the normal marrow have the CD16 ϩ CD44 high CD25 Ϫ CD24 ϩ CD5 Ϫ phenotype and the unrearranged TCR V␤ gene pattern of immature T cell precursors that are similar to stage I DN progenitors in the thymus (11, 14) . CTPs rapidly generate CIPs with rearranged V␤ genes in vitro (1) . In the thymus, rearrangement of the TCR␤ locus is mirrored by the down-regulation of CD16 with the concomitant up-regulation of CD2 (14) and CD5 (13) . The current phenotypic analysis shows that decreased expression of CD16 and increased expression of CD2 and CD5 are associated with rearrangement of V␤ genes in the CIPs. In the thymus, up-regulation of CD25 and down-regulation of CD44 expression indicate progression through the T cell developmental pathway (11) . Unlike DN thymocytes, the CIPs do 
BALB/c wild-type control Although we could not detect RNA for CD3⑀ or TCR V␤8, in the CTPs, the CIPs expressed RNA for both. However, the CTP TCR gene loci was transcriptionally active, as evidenced by the expression of sterile TCR C␤ RNA, but showed no V-J rearrangements. Both CTPs and CIPs expressed RNA for IL-7R␣, Aiolos, an Ikaros-related transcription factor only expressed on lymphoid cells (24, 25) , and for Id2 (26) , a transcription factor involved in fate decision between T vs NK cells. The lack of Notch1 expression in CTPs and CIPs and presence in thymocytes may reflect differences in the kinetics of expression during thymic vs extrathymic T cell development and commitment. Together, the data indicate that CTPs are early committed progenitors, as judged by both surface markers and the expression of a variety of T cellspecific genes.
After adoptive transfer, wild-type CTPs reconstituted mature TCR␣␤ T cells in the lymph nodes, spleen, and bone marrow of adoptive nu/nu hosts at ϳ2 wk after cell transfer, as judged by staining for the TCR␣␤ and the congenic CD45 markers. We could not determine the kinetics of expansion of progenitors vs mature T cells at 1 wk, because there were too few CTP-derived cells to analyze. HSCs from the bone marrow of wild-type donors and CTPs from nu/nu donors were unable to reconstitute the lymphoid tissues. This was expected, because HSCs generate only functionally defective CTPs in the nu/nu bone marrow (3). Reconstitution with wild-type CTPs indicates that the nu/nu lymphoid tissues can support the extrathymic maturation of T cells after the CTP stage of development has been achieved. Control infusions of mature TCR␣␤ ϩ T cells from the wild-type bone marrow showed that expansion of TCR␣␤ ϩ T cells that contaminate the sorted CTPs cannot account for the reconstitution of mature T cells in the irradiated nu/nu lymphoid tissues. Lack of homeostatic expansion of bone marrow TCR␣␤ ϩ T cells was expected, because these T cells produce markedly reduced levels of IL-2 as compared with peripheral T cells (10) . In contrast to the CTPs, CD4
Ϫ CD8 Ϫ CD44 high CD25 Ϫ stage I progenitors in the thymus failed to reconstitute nu/nu hosts despite their similarities in surface phenotype and T cell lineage gene expression.
We found that the injection of 250 CTPs containing one to two precursors generated a normal distribution of V␤ receptors among reconstituted splenic T cells when compared with the distribution among splenic T cells in untreated wild-type BALB/c mice. In addition, the marked reduction in the percentage of T cells expressing V␤3, V␤5, V␤11, and V␤12 as compared with that of C57BL/6 wild-type mice showed that the reconstituted T cells had been appropriately negatively selected. Our previous in vitro studies suggested that the bone marrow stroma can perform the role of positive and negative selection during extrathymic T cell maturation, in the same way that the thymic stroma performs this function during intrathymic T cell maturation (31) .
Functional tests of lymph node T cells from CTP-reconstituted nu/nu hosts showed that the cells vigorously secreted IFN-␥ and but little IL-2 after in vitro stimulation with anti-CD3 and anti-CD28 mAbs. The reconstituted hosts were afforded protection against lethal MCMV infection. Protection against MCMV infection has been reported to be mediated predominantly by CD8 ϩ T cells (32) . The results suggest that the CTP extrathymically derived CD8 ϩ T cells are immunocompetent. These results are consistent with a recent report that CLP (12) can generate CD8 ϩ T cells in irradiated adoptive hosts that contribute to the protection against lethal MCMV infection (34). Interestingly, the protective CD8 ϩ T cells appear to be generated extrathymically, because the percentage of CLP-derived CD8 ϩ T cells in the spleen and protection against MCMV infection were similar in the thymectomized as compared with euthymic allogeneic hosts (34) . CLPprotected hosts had reduced viral loads. The meager secretion of IL-2 and inability of the CTP-derived lymph node cells to mediate GVHD in irradiated BALB/c hosts in the current study indicated that the CTP-derived CD4 ϩ T cells were defective as compared with wild-type CD4 ϩ T cells. In conclusion, we show that CTPs and CIPs are committed T cell lineage progenitors that express T cell-specific genes and gene rearrangements previously reported in the thymus. The data provide evidence that commitment to the T cell lineage can occur in the bone marrow as well as in the thymus, and that these marrow progenitors can generate mature T cells via an extrathymic pathway in athymic nu/nu mice.
